Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study

We studied the feasibility, safety, tolerability and pharmacokinetics of intracerebroventricular delivery of recombinant human vascular endothelial growth factor in patients with amyotrophic lateral sclerosis. In this phase I study in patients with amyotrophic lateral sclerosis, the study drug was d...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Brain Commun
Главные авторы: Van Damme, Philip, Tilkin, Petra, Mercer, Katarina Jansson, Terryn, Joke, D’Hondt, Ann, Herne, Nina, Tousseyn, Thomas, Claeys, Kristl G, Thal, Dietmar R, Zachrisson, Olof, Almqvist, Per, Nuttin, Bart, Jerling, Markus, Bernadotte, Folke, Haegerstrand, Anders, Robberecht, Wim
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8099230/
https://ncbi.nlm.nih.gov/pubmed/33977260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcaa160
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы